Rocco Serrao
Southwest General Health Center(US)Southwest Sciences (United States)(US)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Food Allergy and Anaphylaxis Research, Cancer and Skin Lesions, Urticaria and Related Conditions
Most-Cited Works
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → Palmar Erythema(2007)64 cited
- → Goeckerman treatment for remission of psoriasis refractory to biologic therapy(2009)20 cited
- → Long-Term Efficacy of Dupilumab in Alopecia Areata(2022)14 cited
- → Localized Cutaneous Mucinosis After Joint Replacement(2008)7 cited
- → Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( INTEGUMENT ‐ PED ): A Phase 3 Randomized Controlled Trial(2025)6 cited
- → 639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial(2024)3 cited
- → 671 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis(2024)2 cited
- → Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial(2025)2 cited
- → Topical steroid withdrawal syndrome: developing diagnostic criteria through a modified Delphi method(2025)2 cited